Michael A. Berman, Director at CADENCE PHARMACEUTICALS INC (CADX), bought 300 shares at $9.54 ($3K) on 2006-11-01, disclosed to the SEC on 2008-03-26.
Open-market purchase of $3k CADX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| MDC | SELL | 2019-09-17 | $290K | — | Filing → |
| MDC | SELL | 2019-09-16 | $408K | — | Filing → |
| MDC | SELL | 2019-09-12 | $391K | — | Filing → |